NASH Observatory

⏿ The PanNASH Initiative is an interactive web-based platform presenting global NASH statistics to inform NASH control and research.

Non-alcoholic fatty liver disease in irritable bowel syndrome: More than a coincidence?

Recently, there has been interest in the apparent co-incidence of NAFLD in patients with IBS mainly driven by improved understanding of their shared risk factors and pathophysiology H. Purssell et al. (Manchester University NHS Foundation Trust, UK)......

Read MoreNon-alcoholic fatty liver disease in irritable bowel syndrome: More than a coincidence?

Non-invasive risk stratification in NAFLD/NASH patients for screening esophagogastroduodenoscopy

J. Romano et al. (Medical University of South Carolina, Charleston, USA) evaluated whether these non-invasive markers and/or any other clinical parameters may be used to identify patients with liver cirrhosis who are likely to have large....

Read MoreNon-invasive risk stratification in NAFLD/NASH patients for screening esophagogastroduodenoscopy

Obese and overweight children: screening for early diagnosis of NAFLD is essential

NAFLD is increasingly recognised in obese and overweight children. In this cross-sectional study, S. Thiagarajan et al. (Indira Gandhi Medical College and Research Institute, India) aimed to assess the prevalence of NAFLD in this population and to identify the associated....
Read MoreObese and overweight children: screening for early diagnosis of NAFLD is essential

5Th Global Nash Congress

5Th Global Nash Congress

This slides set presents a detailed review of vascular alterations in non-alcoholic steatohepatitis (NASH) and NASH cirrhosis delivered by Professor Francque, MD, PhD. He highlights that non-fibrotic non-alcoholic fatty liver disease (NAFLD) is accompanied by a significant rise in portal pressure. Professor Francque, also explains the effects of intrahepatic vascular resistance increase in NAFLD. To the clinicians, he provides various patient studies, statistics and clinical data on the subject.

Read More5Th Global Nash Congress

Going beyond the liver in NAFLD/NASH: hepatologist’s / endocrinologist’s perspective

pannash Webinar -2

This multidisciplinary discussion on the diabetologist's and hepatologist's perspectives of non-alcoholic fatty liver disease (NAFLD) / non-alcoholic steatohepatitis (NASH), involves international experts, Dr. Maarten Tushuizen, Prof. A.G (Onno) Holleboom and Prof. Christophe Moreno, together with the chair, Professor Manuel Castor Cabezas. The review addresses NAFLD as a multisystem disease, its epidemiology globally and the significance of developing multidisciplinary care paths.

Read MoreGoing beyond the liver in NAFLD/NASH: hepatologist’s / endocrinologist’s perspective